Immunotherapy Ups Survival Even in Melanoma With Brain Mets Immunotherapy Ups Survival Even in Melanoma With Brain Mets

The use of checkpoint inhibitors significantly improved overall survival and the rate of 4-year survival in patients with stage IV melanoma with brain metastases.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news